GLP-1s can improve long-term health outcomes, reduce obesity, lower cardiovascular risk and ultimately reduce claims over time
If tirzepatide demonstrates cardiovascular benefits, it could become a valuable therapeutic option for individuals with diabetes and cardiovascular risk factors [25]
At her clinic, Barenbaum said she prescribes some GLP-1s off-label, which may involve prescribing a lower dose, most often due to cost and tolerability
This can contribute to: headaches fatigue dizziness Adding a gentle electrolyte powder to water can help maintain hydration levels
Piya S, PhD, Ma H, MS, Piya S, PhD, Ruvolo V, MS, Basyal M, BSc, Golas A, PhD, Windak R, PhD, Rzymski T, PhD, Andreeff M , MD, PhD, Borthakur G, MD